type-1-diabetes

Documents about type-1-diabetes

• Metformin Therapy for Overweight Adolescents With Type 1 Diabetes#28539ClinicalTrials.gov
• Insulin-based Strategies to Prevent Hypoglycemia During Exercise#28540ClinicalTrials.gov
• Nurse Telephone Management of Cholesterol in Diabetes#67770ClinicalTrials.gov
• Desensitization for Highly Sensitized Recipients of Pancreas Transplantation#121242ClinicalTrials.gov
• Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes#121265ClinicalTrials.gov
• The Steno 780G Study#121268ClinicalTrials.gov
• Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes#123636ClinicalTrials.gov
• Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya.#329445ClinicalTrials.gov
• The Management of Glucose Control and Hypoglycemic Prevention Using Continuous Glucose Monitoring System in Patients With Type 1 Diabetes#329466ClinicalTrials.gov
• Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)#329473ClinicalTrials.gov
• In Clinic Evaluation of the PLGM Feature#329478ClinicalTrials.gov
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes#329494ClinicalTrials.gov
• Assessing the Impact of Control-IQ Technology#332665ClinicalTrials.gov
• The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes#332677ClinicalTrials.gov
• Liraglutide in Adolescents With Type 1 Diabetes#337091ClinicalTrials.gov
• Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)#343774ClinicalTrials.gov
• A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus#343780ClinicalTrials.gov
• Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations#346849ClinicalTrials.gov
• Fructose and Glucose and TAS1R2 in Type 1 Diabetes#346850ClinicalTrials.gov
• Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes#346869ClinicalTrials.gov
• Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge#346881ClinicalTrials.gov
• A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients#349904ClinicalTrials.gov
• Transdisciplinary Care for Young Adults With Type 1 Diabetes#353403ClinicalTrials.gov
• A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes#353418ClinicalTrials.gov
• Alemtuzumab Induction in Islet Transplantation#353435ClinicalTrials.gov
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration#356621ClinicalTrials.gov
• The Genetics of Diabetes in Southern California Chinese Americans#356634ClinicalTrials.gov
• Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes#363557ClinicalTrials.gov
• Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes#363573ClinicalTrials.gov
• A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes#366524ClinicalTrials.gov
• Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction#4558Europe PMC
• Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes—the critical role of hypoglycaemia awareness: results from the SFDT1 study#14219HAL (France)
• Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study#14222HAL (France)
• Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes#280246HAL (France)

Related topics